Radiation Sickness

Sorry, no news articles match your request. Your search criteria may be too narrow.

Acute radiation syndrome (ARS) also known as radiation poisoning, radiation sickness or radiation toxicity, is a constellation of health effects which occur within several months of exposure to high amounts of ionizing radiation. The term generally refers to acute problems rather than ones that develop after a prolonged period.

The onset and type of symptoms that develop depends on the dose of radiation exposure. Relatively smaller doses result in gastrointestinal effects such as nausea and vomiting and symptoms related to falling blood counts such as infection and bleeding. Relatively larger doses can result in neurological effects and rapid death. Treatment of acute radiation syndrome is generally supportive with blood transfusions and antibiotics.

Chronic radiation syndrome has been reported among workers in the Soviet nuclear program due to long term exposures to radiation levels lower than what is required to induce acute sickness. It may manifest with low blood cell counts and neurological problems. Radiation exposure can also increase the probability of developing some other diseases, mainly different types of cancers, however these diseases are not included in the term radiation sickness.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Vitamin D link to short-sightedness ruled out

New findings from the Children of the 90s study at the University of Bristol suggest that children with low levels of vitamin D in their blood are not at increased risk of developing myopia (short-sightedness).

Echolocation acts as substitute sense for blind people

Recent research carried out by scientists at Heriot-Watt University has demonstrated that human echolocation operates as a viable 'sense', working in tandem with other senses to deliver information to people with visual impairment.

Bone loss drugs may help prevent endometrial cancer

A new analysis suggests that women who use bisphosphonates—medications commonly used to treat osteoporosis and other bone conditions—have about half the risk of developing endometrial cancer as women who do not use the ...